5) Stock-based Compensation: Schedule of stock inventive plan changes (Tables)

9 Months Ended

Sep. 30, 2017

Tables/Schedules

Schedule of stock inventive plan changes

	Number of Class A Shares	Weighted Average Exercise Price	Number of Class C Shares	Weighted Average Exercise Price
Outstanding at December 31, 2016	741,973	$    4.33	556,298	$     4.61
Granted	-		-
Exercised	-		(103,402)	1.31
Cancelled	-		(24,227)	1.31
Outstanding at September 30, 2017	741,973	$     4.33	428,669	$     5.59
As of September 30, 2017:
Options exercisable	706,854	$     4.21	407,669	$     5.50
As of September 30, 2017:
Available options for future grant	525,682		227,750
Weighted average contractual term of options
outstanding at September 30, 2017	6.62 years		2.63 years
Weighted average contractual term of options
exercisable at September 30, 2017	6.50 years		2.55 years
Aggregated intrinsic value of options
outstanding at September 30, 2017 (1)	$941,567		$151,012
Aggregated intrinsic value of options
exercisable at September 30, 2017 (1)	$941,311		$151,012
(1) The Company used a stock price of $5.10 as of September 30, 2017 to derive intrinsic value.

A summary of the status of the Company’s stock compensation plans as of September 30, 2016, and the changes during the nine months ended September 30, 2016, are presented below:

	Number of Class A Shares	Weighted Average Exercise Price	Number of Class C Shares	Weighted Average Exercise Price
Outstanding at December 31, 2015	618,261	$      3.89	577,436	$      3.54
Granted	-		-
Exercised	(32,417)	2.38	-
Cancelled	-		-
Outstanding at September 30, 2016	585,844	$      3.97	577,436	$      3.54
As of September 30, 2016:
Options exercisable	550,792	$      3.82	551,186	$      3.38
As of September 30, 2016:
Available options for future grant	397,342		57,750
Weighted average contractual term of options
outstanding at September 30, 2016	6.99 years		2.00 years
Weighted average contractual term of options
exercisable at September 30, 2016	6.86 years		1.90 years
Aggregated intrinsic value of options
outstanding at September 30, 2016 (1)	$1,179,541		$1,460,167
Aggregated intrinsic value of options
exercisable at September 30, 2016 (1)	$1,179,541		$1,460,167
(1) The Company used a stock price of $5.86 as of September 30, 2016 to derive intrinsic value.